Literature DB >> 24734882

Soluble urokinase plasminogen activator receptor, the candidate prophetic biomarker in severe inflammatory response syndrome.

B Vasarhelyi1.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24734882     DOI: 10.1111/joim.12259

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


× No keyword cloud information.
  2 in total

1.  Preclinical evaluation of the urokinase receptor-derived peptide UPARANT as an anti-inflammatory drug.

Authors:  Serena Boccella; Elisabetta Panza; Liliana Lista; Carmela Belardo; Angela Ianaro; Mario De Rosa; Vito de Novellis; Vincenzo Pavone
Journal:  Inflamm Res       Date:  2017-04-29       Impact factor: 4.575

2.  The Clinical Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Autoimmune Connective Tissue Disorders.

Authors:  Barna Vasarhelyi; Gergely Toldi; Attila Balog
Journal:  EJIFCC       Date:  2016-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.